Kim H-Y, Zishiri V, Page-Shipp L, Makgopa S, Churchyard G J, Dowdy D, Charalambous S, Hoffmann C J
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Durban.
The Aurum Institute, Johannesburg.
Int J Tuberc Lung Dis. 2020 Mar 1;24(3):295-302. doi: 10.5588/ijtld.19.0214.
Correctional inmates are at a high risk of tuberculosis (TB). The optimal approach to screening this population is unclear. We retrospectively reviewed records from TB screening in 64 correctional facilities in South Africa between January 2015 and July 2016. Inmates received symptom screening (any of cough, fever, weight loss, or night sweats) combined with digital chest X-ray (CXR), when available. CXRs were assessed as 'abnormal' or with no abnormalities. Inmates with either a symptom or an 'abnormal' CXR were asked to provide a single spot sputum for Xpert MTB/RIF testing. We estimated the incremental cost-effectiveness ratio (ICER) per additional TB case detected using CXR screening among asymptomatic inmates. Of 61 580 inmates, CXR screening was available for 41 852. Of these, 19 711 (47.1%) had TB symptoms. Among 22 141 inmates without symptoms, 1939/19 783 (9.8%) had an abnormal CXR, and 8 (1.2%) were Xpert-positive among those with Xpert tests done. Of 14 942 who received symptom screening only and had symptoms, 84% (12 616) had an Xpert result, and 105 (0.8%) were positive. The ICER for CXR screening was US$22 278. Having CXR in addition to symptom screening increased yield but added considerable cost. A major limitation of screening was the low specificity of the symptom screen.
惩教机构中的囚犯患结核病(TB)的风险很高。筛查这一人群的最佳方法尚不清楚。我们回顾性地审查了2015年1月至2016年7月期间南非64个惩教设施的结核病筛查记录。囚犯接受症状筛查(咳嗽、发热、体重减轻或盗汗中的任何一种),并在有条件时结合数字化胸部X光(CXR)检查。CXR检查结果被评估为“异常”或无异常。有症状或CXR“异常”的囚犯被要求提供一份痰标本进行Xpert MTB/RIF检测。我们估计了在无症状囚犯中使用CXR筛查每多发现一例结核病病例的增量成本效益比(ICER)。在61580名囚犯中,有41852人进行了CXR筛查。其中,19711人(47.1%)有结核病症状。在22141名无症状囚犯中,1939/19783人(9.8%)的CXR检查结果异常,在进行Xpert检测的人中,8人(1.2%)Xpert检测呈阳性。CXR筛查的ICER为22278美元。除症状筛查外进行CXR检查可提高检出率,但会增加相当多的成本。筛查的一个主要局限性是症状筛查的特异性较低。